Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03751371 · ClinicalTrials.gov registry record · NA
Robotic Walking Device to Improve Mobility in Parkinson's Disease
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03751371 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 45 participants.
The verdict
NCT03751371, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This Phase II randomized controlled trial proposes to examine the impact of long-term use of a novel light-weight and wearable assistive robotic device, called the Honda Walking Assist (HWA) device, to improve mobility in the home and community in individuals with mild to moderate Parkinson's disease (PD). Specific aims of the project are to: 1) determine the short-term impact of mechanical gait assistance on efficiency and ease of walking in individuals with PD, and 2) determine the effect of long-term HWA device usage on the ease and ability to walk unassisted in the home and community in individuals with PD.
Interventions
- OTHER Usual Care
- DEVICE Training with HWA device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2021-09-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03751371
The ClinicalTrials.gov registry entry for NCT03751371 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03751371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03751371 about?
NCT03751371 is a clinical study titled "Robotic Walking Device to Improve Mobility in Parkinson's Disease". This Phase II randomized controlled trial proposes to examine the impact of long-term use of a novel light-weight and wearable assistive robotic device, called the Honda Walking Assist (HWA) device, to improve mobility in the home and community in individuals with mild to moderate Parkinson's diseas...
What is the current status of trial NCT03751371?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-05-15. Estimated completion is 2021-09-27.
What interventions are being tested in trial NCT03751371?
The interventions under investigation include: Usual Care (OTHER), Training with HWA device (DEVICE).
Who is sponsoring clinical trial NCT03751371?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.